Practicing midnight wake-ups for Nasdaq listing time!! and came across this very concerning article. I have copied first two para’s to provide a brief insight, but have not published the link as its behind my paywall. Hopefully not our first (substantial) setback
Amid calls for a fresh review into the regulator’s call on psychedelics, in-depth interviews by Monash University with politicians, frontline researchers, senior members of mental health peak bodies, a consumer organisation and the union for mental health workers reveal universal concerns that the evidence was “not there yet” to down-schedule the drug.Insiders were concerned there had only been a very small number of clinical trials of psychedelics, with short durations and small sample sizes.”
And so it goes on..in considerable depth..
IHL Price at posting:
9.4¢ Sentiment: Hold Disclosure: Held